Болезнь Шёгрена: мифы и реальность. Часть I
https://doi.org/10.47360/1995-4484-2025-348-356
Аннотация
Стоматологические и офтальмологические проявления болезни Шёгрена (БШ) впервые описаны более 100 лет назад, а в качестве самостоятельной нозологической единицы БШ получила признание в 1965 году. Тем не менее, в настоящее время диагностика и лечение данного заболевания по-прежнему вызывают существенные затруднения в связи с низкой осведомленностью врачей об особенностях течения болезни. В первой части статьи приведены наиболее распространенные и значимые мифы об эпидемиологии и диагностике БШ.
При поддержке: Статья подготовлена в рамках фундаментальной темы (регистрационный № 1021051402790-6)
Об авторах
Б. Д. Чальцев
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
Конфликт интересов:
Россия
Чальцев Богдан Дмитриевич
115522, Москва, Каширское шоссе, 34а
Конфликт интересов:
нет
В. И. Васильев
ООО «Ревмоцентр»
Россия
Конфликт интересов:
Россия
107140, Москва, ул. Нижняя Красносельская, 4
Конфликт интересов:
нет
А. В. Торгашина
ФГБНУ «Научно-исследовательский институт ревматологии им. В.А. Насоновой»
Россия
Конфликт интересов:
Россия
115522, Москва, Каширское шоссе, 34а
Конфликт интересов:
нет
Список литературы
1. Sisó-Almirall A, Kostov B, Martínez-Carbonell E, Brito-Zerón P, Ramirez PB, Acar-Denizli N, et al. The prevalence of 78 autoimmune diseases in Catalonia (MASCAT-PADRIS Big Data Project). Autoimmun Rev. 2020;19(2):102448. doi: 10.1016/j.autrev.2019.102448
2. Qin B, Wang J, Yang Z, Yang M, Ma N, Huang F, et al. Epidemiology of primary Sjögren’s syndrome: A systematic review and meta-analysis. Ann Rheum Dis. 2015;74(11):1983-1989. doi: 10.1136/annrheumdis-2014-205375
3. Vivino FB, Bunya VY, Massaro-Giordano G, Johr CR, Giattino SL, Schorpion A, et al. Sjogren’s syndrome: An update on disease pathogenesis, clinical manifestations and treatment. Clin Immunol. 2019;203:81-121. doi: 10.1016/j.clim.2019.04.009
4. Helmick CG, Felson DT, Lawrence RC, Gabriel S, Hirsch R, Kwoh CK, et al.; National Arthritis Data Workgroup. Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part I. Arthritis Rheum. 2008;58(1):15-25. doi: 10.1002/art.23177
5. Brito-Zerón P, Retamozo S, Ramos-Casals M. Phenotyping Sjögren’s syndrome: Towards a personalised management of the disease. Clin Exp Rheumatol. 2018;36 Suppl 112(3):198-209.
6. Mathews PM, Robinson SA, Gire A, Baer AN, Akpek EK. Extrag-landular ocular involvement and morbidity and mortality in primary Sjögren’s syndrome. PLoS One. 2020;15(9):e0239769. doi: 10.1371/journal.pone.0239769
7. Сафонова ТН, Васильев ВИ, Лихванцева ВГ. Синдром Шёгрена: Руководство для врачей. М.:Издательство Московского государственного университета;2013.
8. Brito-Zerón P, Acar-Denizli N, Ng WF, Zeher M, Rasmussen A, Mandl T, et al.; Sjögren Big Data Consortium. How immunological profile drives clinical phenotype of primary Sjögren’s syndrome at diagnosis: analysis of 10,500 patients (Sjögren Big Data Project). Clin Exp Rheumatol. 2018;36 Suppl 112(3):102-112.
9. Ramos-Casals M, Acar-Denizli N, Vissink A, Brito-Zerón P, Li X, Carubbi F, et al.; Sjogren Big Data Consortium. Childhoodonset of primary Sjögren’s syndrome: Phenotypic characterization at diagnosis of 158 children. Rheumatology (Oxford). 2021;60(10):4558-4567. doi: 10.1093/rheumatology/keab032
10. Shiboski CH, Shiboski SC, Seror R, Criswell LA, Labetoulle M, Lietman TM, et al.; International Sjögren’s Syndrome Criteria Working Group. 2016 American College of Rheumatology/European League Against Rheumatism classification criteria for primary Sjögren’s syndrome: A consensus and data-driven methodology involving three international patient cohorts. Arthritis Rheumatol. 2017;69(1):35-45. doi: 10.1002/art.39859
11. Takagi Y, Hashimoto K, Sasaki M, Eida S, Katayama I, Sumi M. Juvenile onset of primary Sjögren’s syndrome: Changes in imaging findings during a 7-year progression. Clin Exp Rheumatol. 2022;40(12):2466-2467. doi: 10.55563/clinexprheumatol/z3exkq
12. Tomiita M, Saito K, Kohno Y, Shimojo N, Fujikawa S, Niimi H. The clinical features of Sjögren’s syndrome in Japanese children. Acta Paediatr Jpn. 1997;39(2):268-272. doi: 10.1111/j.1442-200x.1997.tb03597.x
13. Houghton K, Malleson P, Cabral D, Petty R, Tucker L. Primary Sjögren’s syndrome in children and adolescents: Are proposed diagnostic criteria applicable? J Rheumatol. 2005;32(11):2225-2232.
14. Vasiliev V, Gaiduk I, Palshina S, Shornikova N, Shornikova L. Lymphomas in patients with juvenile-onset primary Sjogren’s syndrome. Int J Rheum Dis. 2024;27:e15346. doi: 10.1111/1756-185X.15346
15. Chen J, He Q, Yang J, Wu T, Huang Z, Zhang Y, et al. Anti-SSA/SSB-negative primary Sjögren’s syndrome showing different clinical phenotypes: A retrospective study of 934 cases. Adv Rheumatol. 2023;63(1):21. doi: 10.1186/s42358-023-00304-4
16. Грачева ВГ, Васильев ВИ, Симонова МВ, Сафонова ТН, Иванова СМ, и др. Клинико-лабораторная характеристика больных болезнью Шегрена с началом заболевания в молодом возрасте. Терапевтический архив. 1998;70(5):55-58.
17. Чальцев БД, Васильев ВИ, Пальшина СГ, Торгашина АВ, Сокол ЕВ, Хван ЮИ, и др. Сравнительная характеристика клинико-лабораторных особенностей болезни Шегрена с антицентромерными антителами и «классического» субтипа заболевания. Научно-практическая ревматология. 2021;59(2):158-163. doi: 10.47360/1995-4484-2021-158-163
18. Vasiliev V, Palshina S, Gaiduc I, Probatova N., Gorodetskiy V, et al. Marginal zone lymphomas in primary and secondary Sjogren’s syndrome. Clinical and Experimental Rheumatology. 2022:41-42.
19. Насонов ЕЛ (ред.). Ревматология. Российские клинические рекомендации. М.:ГЭОТАР-Медиа;2017. [Nasonov EL (ed.). Rheumatology. Russian clinical recommendations. Moscow:GEOTAR-Media;2017 (In Russ.)].
20. García-Carrasco M, Ramos-Casals M, Rosas J, Pallarés L, Calvo-Alen J, Cervera R, et al. Primary Sjögren syndrome: Clinical and immunologic disease patterns in a cohort of 400 patients. Medicine (Baltimore). 2002;81(4):270-280. doi: 10.1097/00005792-200207000-00003
21. Shiboski SC, Shiboski CH, Criswell L, Baer A, Challacombe S, Lanfranchi H, et al.; Sjögren’s International Collaborative Clinical Alliance (SICCA) Research Groups. American College of Rheumatology classification criteria for Sjögren’s syndrome: A datadriven, expert consensus approach in the Sjögren’s International Collaborative Clinical Alliance cohort. Arthritis Care Res (Hoboken). 2012;64(4):475-487. doi: 10.1002/acr.21591
22. Retamozo S, Akasbi M, Brito-Zerón P, Bosch X, Bove A, Perezde-Lis M, et al. Anti-Ro52 antibody testing influences the classification and clinical characterisation of primary Sjögren’s syndrome. Clin Exp Rheumatol. 2012;30(5):686-692.
23. Decker P, Moulinet T, Pontille F, Cravat M, De Carvalho Bittencourt M, Jaussaud R. An updated review of anti-Ro52 (TRIM21) antibodies impact in connective tissue diseases clinical management. Autoimmun Rev. 2022;21(3):103013. doi: 10.1016/j.autrev.2021.103013
24. ter Borg EJ, Kelder JC. Lower prevalence of extra-glandular mani-festations and anti-SSB antibodies in patients with primary Sjögren’s syndrome and widespread pain: Evidence for a relatively benign subset. Clin Exp Rheumatol. 2014;32(3):349-353.
25. Nishikai M, Akiya K, Tojo T, Onoda N, Tani M, Shimizu K. ‘Seronegative’ Sjögren’s syndrome manifested as a subset of chronic fatigue syndrome. Br J Rheumatol. 1996;35(5):471-474. doi: 10.1093/rheumatology/35.5.471
26. Segal BM, Pogatchnik B, Henn L, Rudser K, Sivils KM. Pain severity and neuropathic pain symptoms in primary Sjögren’s syndrome: A comparison study of seropositive and seronegative Sjögren’s syndrome patients. Arthritis Care Res (Hoboken). 2013;65(8):1291-1298. doi: 10.1002/acr.21956
27. Quartuccio L, Baldini C, Bartoloni E, Priori R, Carubbi F, Corazza L, et al. Anti-SSA/SSB-negative Sjögren’s syndrome shows a lower prevalence of lymphoproliferative manifestations, and a lower risk of lymphoma evolution. Autoimmun Rev. 2015;14(11):1019-1022. doi: 10.1016/j.autrev.2015.07.002
28. Torrente-Segarra V, Corominas H, Sánchez-Piedra C, Fernández Castro M, Andreu JL, Martínez-Taboada VM, et al.; SJOGRENSER Study Group of the Spanish Society of Rheumatology. Fibromyalgia prevalence and associated factors in primary Sjögren’s syndrome patients in a large cohort from the Spanish Society of Rheumatology registry (SJOGRENSER). Clin Exp Rheumatol. 2017;35 Suppl 105(3):28-34.
29. Priori R, Iannuccelli C, Alessandri C, Modesti M, Antonazzo B, Di Lollo AC, et al. Fatigue in Sjogren’s syndrome: Relationship with fibromyalgia, clinical and biologic features. Clin Exp Rheumatol. 2010;28(6 Suppl 63):S82-S86.
30. Ostuni P, Botsios C, Sfriso P, Punzi L, Chieco-Bianchi F, Semerano L, et al. Fibromyalgia in Italian patients with primary Sjögren’s syndrome. Joint Bone Spine. 2002;69(1):51-57. doi: 10.1016/s1297319x(01)00341-4
31. Choi BY, Oh HJ, Lee YJ, Song YW. Prevalence and clinical impact of fibromyalgia in patients with primary Sjögren’s syndrome. Clin Exp Rheumatol. 2016;34(2 Suppl 96):9-13.
32. Dubost JJ, Couderc M, Pereira B, Mariette X, Seror R, Gottenberg JE, et al. Concomitant fibromyalgia in primary Sjögren’s syndrome in the French ASSESS cohort: Comparison of the ACR 1990 and ACR 2016 criteria, FiRST questionnaire and physician’s opinion. Clin Exp Rheumatol. 2021;39 Suppl 133(6):140-145. doi: 10.55563/clinexprheumatol/uxlsh3
33. Klippel J, Stone J, Crofford L, White P. Primer on the rheumatic diseases. 2008. doi: 10.1007/978-0-387-68566-3
34. Whitcher JP Jr, Gritz DC, Daniels TE. The dry eye: A diagnostic dilemma. Int Ophthalmol Clin. 1998;38(4):23-37. doi: 10.1097/00004397-199803840-00005
35. Stankeviciene I, Puriene A, Mieliauskaite D, Stangvaltaite-Mouhat L, Aleksejuniene J. Detection of xerostomia, Sicca, and Sjogren’s syndromes in a national sample of adults. BMC Oral Health. 2021;21(1):552. doi: 10.1186/s12903-021-01917-1
36. Legger GE, Erdtsieck MB, de Wolff L, Stel AJ, Los LI, Verstappen GM, et al. Differences in presentation between paediatricand adult-onset primary Sjögren’s syndrome patients. Clin Exp Rheumatol. 2021;39 Suppl 133(6):85-92. doi: 10.55563/clinexprheumatol/vxe6h0
37. Vasiliev V, Palshina S, Shornicova L, Rodionova E, Novicov A. The course of juvenile onset Sjogren’s syndrome. Clinical and Experimental Rheumatology. 2022:54.
38. Daniels TE. Evaluation, differential diagnosis, and treatment of xerostomia. J Rheumatol Suppl. 2000;61:6-10.
39. Brito-Zerón P, Theander E, Baldini C, Seror R, Retamozo S, Quartuccio L, et al.; Eular Sjögren Syndrome Task Force. Early diagnosis of primary Sjögren’s syndrome: EULAR-SS task force clinical recommendations. Expert Rev Clin Immunol. 2016;12(2):137-156. doi: 10.1586/1744666X.2016.1109449
40. Baldini C, Pepe P, Quartuccio L, Priori R, Bartoloni E, Alunno A, et al. Primary Sjogren’s syndrome as a multi-organ disease: impact of the serological profile on the clinical presentation of the disease in a large cohort of Italian patients. Rheumatology (Oxford). 2014;53(5):839-844. doi: 10.1093/rheumatology/ket427
41. Brito-Zerón P, Izmirly PM, Ramos-Casals M, Buyon JP, Khamashta MA. The clinical spectrum of autoimmune congenital heart block. Nat Rev Rheumatol. 2015;11(5):301-312. doi: 10.1038/nrrheum.2015.29
42. Brito-Zerón P, Pasoto SG, Robles-Marhuenda A, Mandl T, Vissink A, Armagan B, et al.; Sjögren Big Data Consortium. Autoimmune congenital heart block and primary Sjögren’s syndrome: Characterisation and outcomes of 49 cases. Clin Exp Rheumatol. 2020;38 Suppl 126(4):95-102.
43. Stevens WJ, Swartele FE, Empsten FA, De Clerck LS. Use of the Saxon test as a measure of saliva production in a reference population of schoolchildren. Am J Dis Child. 1990;144(5):570-571. doi: 10.1001/archpedi.1990.02150290064029
44. Hershkovich O, Shafat I, Nagler RM. Age-related changes in salivary antioxidant profile: Possible implications for oral cancer. J Gerontol A Biol Sci Med Sci. 2007;62(4):361-366. doi: 10.1093/gerona/62.4.361
45. Nagler RM. Salivary glands and the aging process: Mechanistic aspects, health-status and medicinal-efficacy monitoring. Biogerontology. 2004;5(4):223-233. doi: 10.1023/B:BGEN.0000038023.36727.50
46. Fisher BA, Jonsson R, Daniels T, Bombardieri M, Brown RM, Morgan P, et al.; Sjögren’s histopathology workshop group (appendix) from ESSENTIAL (EULAR Sjögren’s syndrome study group). Standardisation of labial salivary gland histopathology in clinical trials in primary Sjögren’s syndrome. Ann Rheum Dis. 2017;76(7):1161-1168. doi: 10.1136/annrheumdis-2016-210448
47. Parreau S, Nocturne G, Mariette X, Burroni B, Lazure T, Besson FL, et al. Features of non-Hodgkin’s lymphoma diagnosed in minor salivary gland biopsies from primary Sjögren’s syndrome patients. Rheumatology (Oxford). 2022;61(9):3818-3823. doi: 10.1093/rheumatology/keab949
48. Раденска-Лоповок СГ, Каранова МС, Занозин АС. Родионова ЕБ, Пальшина СГ, Цветанов МС, и др. Оценка морфологической активности болезни Шёгрена по биоптатам малых слюнных желез. Архив патологии. 2023;85(1):5-9. doi: 10.17116/patol2023850115
49. Haacke EA, Bootsma H, Spijkervet FKL, Visser A, Vissink A, Kluin PM, et al. FcRL4+ B-cells in salivary glands of primary Sjögren’s syndrome patients. J Autoimmun. 2017;81:90-98. doi: 10.1016/j.jaut.2017.03.012
50. Marx RE, Hartman KS, Rethman KV. A prospective study comparing incisional labial to incisional parotid biopsies in the detection and confirmation of sarcoidosis, Sjögren’s disease, sialosis and lymphoma. J Rheumatol. 1988;15(4):621-629.
51. Васильев ВИ, Пробатова НА, Тупицын НН, Варламова ЕЮ, Логвиненко ОА, Ковригина АМ, и др. Лимфопролиферативные заболевания при болезни Шёгрена. Онкогематология. 2007;2(3):16-26. doi: 10.17650/1818-83462007-0-3-16-26
52. Васильев ВИ, Логвиненко ОА, Пробатова НА, Кокосадзе НВ, Городецкий ВР, Ковригина АМ, и др. Роль биопсии околоушной слюнной железы в ранней диагностике лимфом при болезни Шёгрена. Терапевтический архив. 2009;81(6):2026.
53. Pijpe J, Kalk WW, van der Wal JE, Vissink A, Kluin PM, Roodenburg JL, et al. Parotid gland biopsy compared with labial biopsy in the diagnosis of patients with primary Sjogren’s syndrome. Rheumatology (Oxford). 2007;46(2):335-341. doi: 10.1093/rheumatology/kel266
54. Spijkervet FK, Haacke E, Kroese FG, Bootsma H, Vissink A. Parotid gland biopsy, the alternative way to diagnose sjögren syndrome. Rheum Dis Clin North Am. 2016;42(3):485-499. doi: 10.1016/j.rdc.2016.03.007
55. Clark M, Walsh H, Stephens-Laborde I, Khurram SA. The value of labial gland biopsies as a diagnostic test for Sjögren’s syndrome. Head Neck Pathol. 2024;18(1):64. doi: 10.1007/s12105024-01662-1
56. Risselada AP, Kruize AA, Goldschmeding R, Lafeber FP, Bijlsma JW, van Roon JA. The prognostic value of routinely performed minor salivary gland assessments in primary Sjögren’s syndrome. Ann Rheum Dis. 2014;73(8):1537-1540. doi: 10.1136/annrheumdis-2013-204634
57. Bodeutsch C, de Wilde PC, Kater L, van den Hoogen FH, Hené RJ, van Houwelingen JC, et al. Monotypic plasma cells in labial salivary glands of patients with Sjögren’s syndrome: Prognosticator for systemic lymphoproliferative disease. J Clin Pathol. 1993;46(2):123-128. doi: 10.1136/jcp.46.2.123
58. Theander E, Vasaitis L, Baecklund E, Nordmark G, Warfvinge G, Liedholm R, et al. Lymphoid organisation in labial salivary gland biopsies is a possible predictor for the development of malignant lymphoma in primary Sjögren’s syndrome. Ann Rheum Dis. 2011;70(8):1363-1368. doi: 10.1136/ard.2010.144782
59. Родионова ЕБ, Васильев ВИ, Прокопенко ВД, Логвиненко ОА. Антиген-представляющие клетки лимфогистиоцитарного инфильтрата при болезни Шегрена. Научно-практическая ревматология. 2006;3:16-19.
60. Paschides CA, Kitsios G, Karakostas KX, Psillas C, Moutsopoulos HM. Evaluation of tear break-up time, Schirmer’s-I test and rose bengal staining as confirmatory tests for keratoconjunctivitis sicca. Clin Exp Rheumatol. 1989;7(2):155-157.
61. Whitcher JP, Shiboski CH, Shiboski SC, Heidenreich AM, Kitagawa K, Zhang S, et al.; Sjögren’s International Collaborative Clinical Alliance Research Groups. A simplified quantitative method for assessing keratoconjunctivitis sicca from the Sjögren’s Syndrome International Registry. Am J Ophthalmol. 2010;149(3):405-415. doi: 10.1016/j.ajo.2009.09.013
62. Wang B, Chen S, Zheng Q, Li Y, Zhang X, Xuan J, et al. Early diagnosis and treatment for Sjögren’s syndrome: Current challenges, redefined disease stages and future prospects. J Autoimmun. 2021;117:102590. doi: 10.1016/j.jaut.2020.102590
63. Васильев ВИ, Логвиненко ОА, Симонова МВ, Сафонова ТН, Раденска-Лоповок СГ, Божьева ЛА, и др. Развитие сухого синдрома при саркоидозе с поражением слюнных и слезных желез. Терапевтический архив. 2005;77(1):62-67
64. Mathew R, Zeppieri M. Ocular amyloidosis. Treasure Island (FL): StatPearls Publishing; 2024.
65. Schonberg S, Stokkermans TJ. Ocular pemphigoid. Treasure Island (FL):StatPearls Publishing; 2023.
66. Golden MI, Meyer JJ, Zeppieri M, Patel BC. Dry eye syndrome. Treasure Island (FL):StatPearls Publishing; 2024.
67. Bjerrum KB. Keratoconjunctivitis sicca and primary Sjögren’s syndrome in a Danish population aged 30–60 years. Acta Ophthalmol Scand. 1997;75(3):281-286. doi: 10.1111/j.1600-0420.1997.tb00774.x
68. Forstot JZ, Forstot SL, Greer RO, Tan EM. The incidence of Sjögren’s sicca complex in a population of patients with keratoconjunctivitis sicca. Arthritis Rheum. 1982;25(2):156-160. doi: 10.1002/art.1780250207
69. Kruize AA, Hené RJ, van der Heide A, Bodeutsch C, de Wilde PC, van Bijsterveld OP, et al. Long-term followup of patients with Sjögren’s syndrome. Arthritis Rheum. 1996;39(2):297-303. doi: 10.1002/art.1780390219
70. Kruize AA, van Bijsterveld OP, Hené RJ, de Wilde PC, Feltkamp TE, Kater L, et al. Long-term course of tear gland function in patients with keratoconjunctivitis sicca and Sjögren’s syndrome. Br J Ophthalmol. 1997;81(6):435-438. doi: 10.1136/bjo.81.6.435
71. Ramsubeik K, Motilal S, Sanchez-Ramos L, Ramrattan LA, Kaeley GS, Singh JA. Diagnostic accuracy of salivary gland ultrasound in Sjögren’s syndrome: A systematic review and meta-analysis. Ther Adv Musculoskelet Dis. 2020;12:1759720X20973560. doi: 10.1177/1759720X20973560
72. Narayan AK, Baer A, Fradin J. Sonographic findings of IgG4related disease of the salivary glands: Case report and review of the literature. J Clin Ultrasound. 2018;46(1):73-77. doi: 10.1002/jcu.22482
73. Lorenzon M, Tulipano Di Franco F, Zabotti A, Pegolo E, Giovannini I, Manfrè V, et al. Sonographic features of lymphoma of the major salivary glands diagnosed with ultrasound-guided core needle biopsy in Sjögren’s syndrome. Clin Exp Rheumatol. 2021;39 Suppl 133(6):175-183. doi: 10.55563/clinexprheumatol/4c36nr
74. Orita Y, Sato Y, Kimura N, Marunaka H, Tachibana T, Yamashita Y, et al. Characteristic ultrasound features of mucosa-associated lymphoid tissue lymphoma of the salivary and thyroid gland. Acta Otolaryngol. 2014;134(1):93-99. doi: 10.3109/00016489.2013.831994
Рецензия
Для цитирования:
Чальцев Б.Д., Васильев В.И., Торгашина А.В. Болезнь Шёгрена: мифы и реальность. Часть I. Научно-практическая ревматология. 2025;63(4):348-356. https://doi.org/10.47360/1995-4484-2025-348-356
For citation:
Chaltsev B.D., Vasilyev V.I., Torgashina A.V. Myths and reality. Part I. Rheumatology Science and Practice. 2025;63(4):348-356. (In Russ.) https://doi.org/10.47360/1995-4484-2025-348-356
Просмотров:
27
Послать статью по эл. почте 